Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B

被引：0

作者：

Kim, D. Y. ^{[1
]}

Lee, J. M. ^{[1
]}

Ahn, S. H. ^{[1
]}

Lee, Y. C. ^{[1
]}

Lee, D. K. ^{[1
]}

Chung, J. B. ^{[1
]}

Chon, C. Y. ^{[1
]}

Han, K-H ^{[1
]}

机构：

[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2009年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：A176 / A176

页数：1

共 50 条

[1] Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B
Lee, Jung Min
Park, Jun Yong
Kim, Do Young
Nguyen, Tin
Hong, Sun Pyo
Kim, Soo Ok
Chon, Chae Yoon
Han, Kwang-Hyub
Ahn, Sang Hoon
ANTIVIRAL THERAPY, 2010, 15 (02) : 235 - 241
[2] LONG-TERM ADEFOVIR DIPIVOXIL MONOTHERAPY FOR UP TO 5 YEARS IN LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B
Lee, Jung Min
Park, Jun Yong
Kim, Do Young
Nguyen, Tin
Hong, Sunpyo
Lee, Kwan Sik
Moon, Byung Soo
Han, Kwang-Hyub
Chon, Chae Yoon
Moon, Young Myoung
Ahn, Sang Hoon
HEPATOLOGY, 2009, 50 (04) : 504A - 504A
[3] Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B
Dai, Chia-Yen
Chuang, Wan-Long
Hsieh, Ming-Yen
Lee, Li-Po
Huang, Jee-Fu
Hou, Nai-Jen
Lin, Zu-Yau
Chen, Shinn-Cherng
Hsieh, Ming-Yuh
Wang, Liang-Yen
Tsai, Jun-Fa
Chang, Wen-Yu
Yu, Ming-Lung
ANTIVIRAL RESEARCH, 2007, 75 (02) : 146 - 151
[4] Comparative meta-analysis of adefovir dipivoxil monotherapy and combination therapy of adefovir dipivoxil and lamivudine for lamivudine-resistant chronic hepatitis B
Chen, YongFa
Ju, Ting
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (03) : E152 - E158
[5] Long-term outcomes of add-on adefovir dipivoxil therapy to ongoing lamivudine in patients with lamivudine-resistant chronic hepatitis B
Toyama, Takashi
Ishida, Hisashi
Ishibashi, Hiromi
Yatsuhashi, Hiroshi
Nakamuta, Makoto
Shimada, Masaaki
Ohta, Hajime
Satoh, Takeaki
Kato, Michio
Hijioka, Taizo
Takano, Hirotsugu
Komeda, Toshiki
Yagura, Michiyasu
Mano, Hiroshi
Watanabe, Yukio
Kobayashi, Masakazu
Mita, Eiji
HEPATOLOGY RESEARCH, 2012, 42 (12) : 1168 - 1174
[6] Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B
Peters, MG
Hann, HW
Martin, P
Heathcote, EJ
Buggisch, P
Rubin, R
Bourliere, M
Kowdley, K
Trepo, C
Gray, DF
Sullivan, M
Kleber, K
Ebrahimi, R
Xiong, S
Brosgart, CL
GASTROENTEROLOGY, 2004, 126 (01) : 91 - 101
[7] Adefovir dipivoxil plus lamivudine combination treatment is superior to adefovir dipivoxil monotherapy in lamivudine-resistant hepatitis B E antigen-negative chronic hepatitis B patients
Vassiliadis, Themistoklis
Giouleme, Olga
Koumerkeridis, Georgios
Charalompos, Koumaras
Tziomalos, Konstantinos
Patsiaoura, Koliopi
Mpoumponaris, Alexander
Gkisakis, Dimitrios
Theodoropoulos, Konstantinos
Grammatikos, Nikolaos
Panderi, Athanasia
Nikolaidis, Nikolaos
Evgenidis, Nikolaos
HEPATOLOGY, 2007, 46 (04) : 662A - 663A
[8] Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants
Perrillo, R
Schiff, E
Yoshida, E
Statler, A
Hirsch, K
Wright, T
Gutfreund, K
Lamy, P
Murray, A
HEPATOLOGY, 2000, 32 (01) : 129 - 134
[9] Short-term overlap lamivudine treatment with adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B
Nam, Soon Woo
Bae, Si Hyun
Lee, Seung Woo
Kim, Yeon Soo
Kang, Sang Bum
Choi, Long Young
Cho, Se Hyun
Ybon, Seung Kew
Han, Joon-Yeol
Yang, Jin Mo
Lee, Young Suk
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (11) : 1781 - 1784
[10] Resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B.
Osiowy, C
Heathcote, J
Zoulim, F
Willems, B
Villeneuve, JP
HEPATOLOGY, 2005, 42 (04) : 586A - 587A

← 1 2 3 4 5 →